Effectiveness of duloxetine and venlafaxine in producing increases in extracellular levels of serotonin and norepinephrine in brain

被引：0

作者：

Wong, DT ^{[1
]}

Bymaster, FP ^{[1
]}

Dreshfield-Ahmad, L ^{[1
]}

机构：

[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA

来源：

JOURNAL OF AFFECTIVE DISORDERS | 2002年 / 68卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：105 / 106

页数：2

共 50 条

[11] Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes and other neuronal receptors [J].

Luecke, SK ;

Wong, DT ;

Ahmad, LJ ;

Threlkeld, PG ;

Shaw, JL ;

Thompson, LK ;

Iyengar, S ;

Nelson, DL ;

Bymaster, FP .

BIOLOGICAL PSYCHIATRY, 2001, 49 (08) :162S-162S

[12] EFFECT OF IPRONIAZID ON BRAIN LEVELS OF NOREPINEPHRINE AND SEROTONIN [J].

SPECTOR, S ;

PROCKOP, D ;

SHORE, PA ;

BRODIE, BB .

SCIENCE, 1958, 127 (3300) :704-704

[13] Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex [J].

Frank P. Bymaster ;

Wei Zhang ;

Petra A. Carter ;

Janice Shaw ;

Eyassu Chernet ;

Lee Phebus ;

David T. Wong ;

Kenneth W. Perry .

Psychopharmacology, 2002, 160 :353-361

[14] Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex [J].

Bymaster, FP ;

Zhang, W ;

Carter, PA ;

Shaw, J ;

Chernet, E ;

Phebus, L ;

Wong, DT ;

Perry, KW .

PSYCHOPHARMACOLOGY, 2002, 160 (04) :353-361

[15] DULOXETINE ELEVATES EXTRACELLULAR SEROTONIN (5-HT) AND NOREPINEPHRINE (NE) IN HYPOTHALAMUS IN-VIVO [J].

WONG, DT ;

PERRY, KW ;

ENGLEMAN, EA .

FASEB JOURNAL, 1994, 8 (04) :A107-A107

[16] Duloxetine Increases Serotonin and Norepinephrine Availability in Healthy Subjects: A Double-Blind, Controlled Study [J].

Stephan A Chalon ;

Luc-André Granier ;

François R Vandenhende ;

Peter R Bieck ;

Frank P Bymaster ;

Melissa J Joliat ;

Christine Hirth ;

William Z Potter .

Neuropsychopharmacology, 2003, 28 :1685-1693

[17] Duloxetine increases serotonin and norepinephrine availability in healthy subjects: A double-blind, controlled study [J].

Chalon, SA ;

Granier, LA ;

Vandenhende, FR ;

Bieck, PR ;

Bymaster, FP ;

Joliat, MJ ;

Hirth, C ;

Potter, WZ .

NEUROPSYCHOPHARMACOLOGY, 2003, 28 (09) :1685-1693

[18] Differential inhibition of cardiac and neuronal Na+ channels by the selective serotonin-norepinephrine reuptake inhibitors duloxetine and venlafaxine [J].

Stoetzer, Carsten ;

Papenberg, Bastian ;

Doll, Thorben ;

Voelker, Marc ;

Heineke, Joerg ;

Stoetzer, Marcus ;

Wegner, Florian ;

Leffler, Andreas .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 783 :1-10

[19] Blockade of the serotonin and norepinephrine uptake processes by duloxetine: In vitro and in vivo studies in the rat brain [J].

Kasamo, K ;

Blier, P ;

deMontigny, C .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 277 (01) :278-286

[20] Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain [J].

Gould, Georgianna G. ;

Javors, Martin A. ;

Frazer, Alan .

BIOLOGICAL PSYCHIATRY, 2007, 61 (02) :210-215

← 1 2 3 4 5 →